S 79
Interagency Patent Coordination and Improvement Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill establishes an interagency task force between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) to improve coordination and information sharing regarding patents for human drugs and biological products. The task force will share information on agency processes, new approvals, and scientific developments, and require the PTO to request relevant FDA information to assist patent examiners. It also aims to streamline the process for listing patents and protect confidential information.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Dianne Feinstein
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.